Sara Dill, MD
Dermatology · Santa Barbara, CANPI 1578573358
Payments from drug & device makers
Across 486 payments — averaging $1384.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$644K
- Almirall LLC$14K
- Krystal Biotech Inc$9K
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$687
- Dermavant Sciences, Inc.$565
- Sun Pharmaceutical Industries Inc.$465
- plus $4K from 21 others
Across 7 payments — averaging $4716.96 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$33K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 323 | $643,900 |
| Almirall LLC | 8 | $14,129 |
| Krystal Biotech Inc | 4 | $9,377 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 8 | $687 |
| Dermavant Sciences, Inc. | 8 | $565 |
| Sun Pharmaceutical Industries Inc. | 12 | $465 |
| Lilly USA, LLC | 18 | $415 |
| Sanofi | 14 | $387 |
| Novartis | 21 | $369 |
| Johnson & Johnson | 10 | $337 |
| Pfizer | 12 | $299 |
| Regeneron Healthcare Solutions, Inc. | 5 | $264 |
| Incyte Corporation | 8 | $185 |
| Revance Therapeutics, Inc. | 2 | $162 |
| Strata Skin Sciences, Inc. | 1 | $144 |
| Dermira, Inc. | 2 | $130 |
| Bristol Myers Squibb | 2 | $129 |
| E.r. Squibb & Sons, L.L.C. | 3 | $129 |
| UCB, Inc. | 4 | $126 |
| LEO Pharma Inc. | 5 | $121 |
| Verrica Pharmaceuticals Inc. | 1 | $98 |
| Amgen | 3 | $77 |
| Galderma Laboratories, L.p. | 4 | $76 |
| VYNE Pharmaceuticals Inc. | 3 | $52 |
| Arcutis Biotherapeutics, Inc. | 1 | $16 |
| Biofrontera Inc. | 2 | $14 |
| EPI Health, LLC | 2 | $10 |
How this compares
$672,664 in reported general payments places this provider in the 95th percentile of 1,875 dermatology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Santa Barbara
- Vivian LaquerIrvine$20.9M
- Howard SofenLos Angeles$16.1M
- Raja SivamaniSacramento$11.8M
- Jennifer SoungSanta Ana$10.3M
- Stacy SmithEncinitas$7.9M
- Paul YamauchiSanta Monica$7.8M
- Navid EzraThousand Oaks$7.8M
- Paul WallaceBeverly Hills$7.1M
- April ArmstrongLos Angeles$6.2M
- David RayhanHuntington Beach$5.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.